396 related articles for article (PubMed ID: 26847715)
1. Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?
Mekinian A; Cohen J; Alijotas-Reig J; Carbillon L; Nicaise-Roland P; Kayem G; Daraï E; Fain O; Bornes M
Am J Reprod Immunol; 2016 Jul; 76(1):8-28. PubMed ID: 26847715
[TBL] [Abstract][Full Text] [Related]
2. Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth.
Kolanska K; Dabi Y; Dechartres A; Cohen J; Ben Kraiem Y; Selleret L; Mathieu d'Argent E; Placais L; Cheloufi M; Johanet C; Rosefort A; Bornes M; Suner L; Delhommeau F; Ledée N; Chabbert Buffet N; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
Am J Reprod Immunol; 2021 Aug; 86(2):e13425. PubMed ID: 33772927
[TBL] [Abstract][Full Text] [Related]
3. Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.
Plaçais L; Kolanska K; Kraiem YB; Cohen J; Suner L; Bornes M; Sedille L; Rosefort A; D'Argent EM; Selleret L; Abisror N; Johanet C; Buffet NC; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():100-104. PubMed ID: 32592916
[TBL] [Abstract][Full Text] [Related]
4. Does immunotherapy for treatment of reproductive failure enhance live births?
Coulam CB; Acacio B
Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
[TBL] [Abstract][Full Text] [Related]
5. The effects of immunotherapy with intravenous immunoglobulins versus no intervention, placebo, or usual care in patients with recurrent miscarriages: a protocol for a systematic review with meta-analyses, trial sequential analyses, and individual patient data meta-analyses of randomised clinical trials.
Egerup P; Lindschou J; Gluud C; Christiansen OB
Syst Rev; 2014 Aug; 3():89. PubMed ID: 25128005
[TBL] [Abstract][Full Text] [Related]
6. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis.
Woon EV; Day A; Bracewell-Milnes T; Male V; Johnson M
J Reprod Immunol; 2020 Nov; 142():103189. PubMed ID: 32889304
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization/intracytoplasmic sperm injection.
Nyborg KM; Kolte AM; Larsen EC; Christiansen OB
Fertil Steril; 2014 Dec; 102(6):1650-5.e1. PubMed ID: 25256927
[TBL] [Abstract][Full Text] [Related]
9. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S
N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572
[TBL] [Abstract][Full Text] [Related]
10. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.
Stephenson MD; Kutteh WH; Purkiss S; Librach C; Schultz P; Houlihan E; Liao C
Hum Reprod; 2010 Sep; 25(9):2203-9. PubMed ID: 20634190
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
Dendrinos S; Sakkas E; Makrakis E
Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
[TBL] [Abstract][Full Text] [Related]
14. The Impact of New Immunological Therapeutic Strategies on Recurrent Miscarriage and Recurrent Implantation Failure.
Parhizkar F; Motavalli-Khiavi R; Aghebati-Maleki L; Parhizkar Z; Pourakbari R; Kafil HS; Danaii S; Yousefi M
Immunol Lett; 2021 Aug; 236():20-30. PubMed ID: 34090942
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
Sapir T; Carp H; Shoenfeld Y
Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
[TBL] [Abstract][Full Text] [Related]
16. Antagonists of TNFα for recurrent miscarriages: 2 Illustrative cases.
Mekinian A; Houfflin-Debarge V; Kolanska K; Cohen J; Abisror N; Bornes M; Kayem G; Fain O
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():263-264. PubMed ID: 30872045
[TBL] [Abstract][Full Text] [Related]
17. Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.
Sung N; Khan SA; Yiu ME; Jubiz G; Salazar MD; Skariah A; Dambaeva S; Kwak-Kim J
J Reprod Immunol; 2021 Nov; 148():103369. PubMed ID: 34492567
[TBL] [Abstract][Full Text] [Related]
18. [Unexplained recurrent early miscarriages: Role of immunomodulation?].
Mekinian A; Cohen J; Kayem G; Carbillon L; Nicaise-Roland P; Gaugler B; Darai E; Bornes M; Fain O
Rev Med Interne; 2017 Apr; 38(4):264-268. PubMed ID: 27751562
[TBL] [Abstract][Full Text] [Related]
19. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages.
Dolitzky M; Inbal A; Segal Y; Weiss A; Brenner B; Carp H
Fertil Steril; 2006 Aug; 86(2):362-6. PubMed ID: 16769056
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of IVIG therapy in pregnancy and live birth rate of women with recurrent implantation failure (RIF): A systematic review and meta-analysis.
Abdolmohammadi-Vahid S; Pashazadeh F; Pourmoghaddam Z; Aghebati-Maleki L; Abdollahi-Fard S; Yousefi M
J Reprod Immunol; 2019 Sep; 134-135():28-33. PubMed ID: 31425838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
